title: Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions.
abstract: Autoreactive T cells play a major role in the development of insulin-dependent diabetes mellitus, suggesting that costimulatory molecules that regulate T cell responses might be essential for disease progression. In NOD mice, CD28/B7 and CD40/CD40 ligand (L) interactions control the onset of diabetes from 2 to 4 weeks of age, but blocking these molecules has little effect after this time. Hence, it is possible that other ligand/receptor pairs control a later phase of disease. We now show that OX40 is expressed on CD4 and CD8 T cells several weeks prior to islet destruction, which is initiated around weeks 12-14, and that OX40L is present on dendritic cells in both secondary lymphoid organs and the pancreas from 11 to 13 weeks of age. Blocking OX40L at 6, 9, or 15 weeks after birth had little effect on disease; however, inhibiting OX40/OX40L interactions at week 12, or continuous treatment from week 12 onwards, significantly reduced the incidence of diabetes. Histological examination showed that islet destruction was prevented and insulitis reduced by targeting OX40L. These studies show that OX40/OX40L interactions form a late checkpoint in diabetes development and suggest that these molecules are realistic targets for therapeutic intervention.
authors.affiliation: Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA.
authors.forename: Syamasundar V
authors.initials: SV
authors.lastname: Pakala
authors.forename: Pratima
authors.initials: P
authors.lastname: Bansal-Pakala
authors.forename: Beth S
authors.initials: BS
authors.lastname: Halteman
authors.forename: Michael
authors.initials: M
authors.lastname: Croft
mesh_terms: D000818:Animals; D019138:Antibodies, Blocking / Q000276:immunology / Q000494:pharmacology; D000943:Antigens, Differentiation / Q000276:immunology* / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000517:prevention & control*; D005260:Female; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D016688:Mice, Inbred NOD; D053278:OX40 Ligand; D010179:Pancreas / Q000276:immunology / Q000473:pathology; D013154:Spleen / Q000276:immunology; D018709:Statistics, Nonparametric; D048069:Tumor Necrosis Factors
chemical_list: D019138:Antibodies, Blocking; D000943:Antigens, Differentiation; D008562:Membrane Glycoproteins; D053278:OX40 Ligand; C406562:OX40Ig; C504586:Tnfsf4 protein, mouse; D048069:Tumor Necrosis Factors